Some doctors helping evaluate the effectiveness of an increasingly popular device for clearing clogged arteries own stock and options in the company that makes it, regulatory filings show.

ProAssurance enters into a definitive agreement to be acquired by The Doctors Company for $25 per share in cash. The transaction is expected to close in the first half of 2026. Get 5 ‘Hidden Gem ...